Ovarian Cancer News

News

From July 2025, the cervical screening programme in England will be changing. Women and people with a cervix aged 25 to 64 will now be invited for routine cervical screening every five years – an increase from the current three-year interval for those under 50.

News

A recent storyline on BBC Casualty has taken a bold and important turn, focusing on ovarian cancer, a disease that often goes undetected until it's advanced. We're proud to be part of the team helping make sure Stevie’s journey was portrayed with accuracy, empathy and impact.

News

We’re proud to announce something that could be truly transformational in the lives of women with ovarian cancer: a $1 million global grant - powered by a game-changing collaboration with leading ovarian cancer research charities worldwide.

News

The latest decision from NICE gives access to this drug at an earlier stage for eligible women. This means they can begin taking this maintenance drug straight after their first-line chemotherapy, rather than waiting to see if the disease comes back.

News

This March, we’re raising awareness of a deeply concerning fact: 1 year survival rates in ovarian cancer have barely improved  in the last 10 years. While we want to highlight  this lack of progress, our supporters will know this isn’t the whole story.

News

The Kennel Club has announced the five finalists for its prestigious Hero Dog of the Year Award at Crufts, and among them is Louis, the incredible English Sett…

News

Ovarian Cancer Action, the UK’s leading ovarian cancer research charity, has appointed Claire Gillis, Global CEO of VML Health, as its new Chair of the Board.

News

The festive season is a time for reflection and gratitude. This year, we have even more to be thankful for, thanks to your unwavering support. Take a look at the progress you supported with your donations.

News

Following the Government’s call for ideas, Ovarian Cancer Action submitted its vision for the next 10 years of the NHS to improve survival rates for women with ovarian cancer. Learn more about our submission and why we think the next ten years can be transformative.

News

After nearly a decade of campaigning, Ovarian Cancer Action reviews the findings in the government-funded National Ovarian Cancer Audit. This milestone follows their groundbreaking feasibility pilot, which highlighted urgent inequalities in diagnosis and treatment. Learn how supporter action and advocacy helped make this audit a reality.

News

Discover how Ovarian Cancer Action’s 2019 HHMT Forum helped spark groundbreaking ovarian cancer immunotherapy research, leading to a promising vaccine now funded by Cancer Research UK. See how global collaboration is driving progress.

News

Our Research Grants and Impacts Manager, talks us through a patient involvement workshop held with Professor Ahmed whilst he was developing his research on ovarian cancer vaccines and why the patient voice is crucial to pushing key research forward.

News

Groundbreaking research funded by Ovarian Cancer Action has received a major boost from Cancer Research UK to develop the world’s first vaccine to prevent ovarian cancer. Discover how this innovative project could save lives.

News

Researchers have been exploring whether testing women with symptoms that might be linked to ovarian cancer is a good way to find aggressive types of the disease early. Find out more about symptoms-triggered testing and why screening research is still important for ovarian cancer survival rates.

News

Ovarian Cancer Action joins 21 other funders of cancer research wishing to maximise the value and benefits of cancer research for patients and the public.

News

The brand new NICE guideline ‘Ovarian cancer: identifying and managing familial and genetic risk’ has been published today. We break down what it means.

News

We outline what the programme is and answer some common questions.

News

At Ovarian Cancer Action, we want all women to survive ovarian cancer. We’re determined to make sure every woman gets the treatment they need when they need it. For World Cancer Day 2024, we went to the Houses of Parliament, alongside 20 cancer charities, to call on the Government and opposition parties to drastically reduce waiting times for cancer patients.

News

The National Institute for Health and Care Excellence have approved the combination of olaparib with bevacizumab for the maintenance treatment of high-grade epithelial ovarian cancer, fallopian tube cancer or primary peritoneal cancer.

News

We explore why women with a high inherited risk of cancer might opt to have their ovaries removed at the same time as having a caesarean section.